69604-204Level 3
Anthim (obiltoxaximab)
**Product type:** Human Prescription Drug
**Active ingredient:** OBILTOXAXIMAB
**Strength:** 100 mg/mL
**Dosage form:** Solution
**Route:** Intravenous
**Labeler:** Elusys Therapeutics, Inc.
**Marketing category:** BLA (BLA125509)
**Pharmacologic class:** Anthrax Protective Antigen-directed Antibody Interactions [MoA], Anthrax Protective Antigen-directed Antibody [EPC]
GET
/api/v1/systems/ndc_fda/nodes/69604-204Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.